Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Sep 15;51(6):1146-54.
doi: 10.1016/j.freeradbiomed.2011.05.041. Epub 2011 Jun 13.

2',5'-Dihydroxychalcone-induced glutathione is mediated by oxidative stress and kinase signaling pathways

Affiliations

2',5'-Dihydroxychalcone-induced glutathione is mediated by oxidative stress and kinase signaling pathways

Remy Kachadourian et al. Free Radic Biol Med. .

Abstract

Hydroxychalcones are naturally occurring compounds that continue to attract considerable interest because of their anti-inflammatory and antiangiogenic properties. They have been reported to inhibit the synthesis of the inducible nitric oxide synthase and to induce the expression of heme oxygenase-1. This study examines the mechanisms by which 2',5'-dihydroxychalcone (2',5'-DHC) induces an increase in cellular glutathione (GSH) levels using a cell line stably expressing a luciferase reporter gene driven by antioxidant-response elements (MCF-7/AREc32). The 2',5'-DHC-induced increase in cellular GSH levels was partially inhibited by the catalytic antioxidant MnTDE-1,3-IP(5+), suggesting that reactive oxygen species (ROS) mediate the antioxidant adaptive response. 2',5'-DHC treatment induced phosphorylation of the c-Jun N-terminal kinase (JNK) pathway, which was also inhibited by MnTDE-1,3-IP(5+). These findings suggest a ROS-dependent activation of the AP-1 transcriptional response. However, whereas 2',5'-DHC triggered the NF-E2-related factor 2 (Nrf2) transcriptional response, cotreatment with MnTDE-1,3-IP(5+) did not decrease 2',5'-DHC-induced Nrf2/ARE activity, showing that this pathway is not dependent on ROS. Moreover, pharmacological inhibitors of mitogen-activated protein kinase (MAPK) pathways showed a role for JNK and p38MAPK in mediating the 2',5'-DHC-induced Nrf2 response. These findings suggest that the 2',5'-DHC-induced increase in GSH levels results from a combination of ROS-dependent and ROS-independent pathways.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Structures of chalcone, 2′-hydroxychalcone (2′-HC), 2′,5′-dihydroxychalcone (2′,5′-DHC) and the flavonoid chrysin.
Fig. 2
Fig. 2
2′,5′-DHC induces oxidative stress. (A) 2′,5′-DHC (40 μM)-induced cytotoxicity was increased by the GSH synthesis inhibitor BSO (20 μM) and diminished by the catalytic antioxidant MnTDE-1,3-IP5+ (MnP, 10–20 μM) (48 h treatment). N-acetyl cysteine (NAC, 1 mM) did not protect the cells against 2′,5′-DHC-induced cytotoxicity. Bars with different letters were statistically different from one another (n = 4, P < 0.05). (B) As shown by microscopy using MitoSOX as dye, 2′,5′-DHC (40 μM) induced an increase in ROS-induced fluorescence that was diminished by MnTDE-1,3-IP5+ (MnP, 10 μM) (24 h treatment). (C) As shown by flow cytometry using MitoSOX as dye, a non-toxic concentration of 2′,5′-DHC (10 μM) induced a temporary increase in fluorescence at 1 h treatment (n = 3).
Fig. 3
Fig. 3
2′,5′-DHC-induced increase in iGSH levels is inhibited by MnTDE-1,3-IP5+. (A) 2′,5′-DHC (10 μM) induced a drop (6 h) followed by an increase (24 h) of iGSH levels, whereas chrysin (Chr, 10 μM) induced only a drop of iGSH levels (n = 3). (B) MnTDE-1,3-IP5+ (MnP, 10 μM) significantly inhibited the 2′,5′-DHC-induced increase in iGSH levels, while NAC (1 mM) did not (n = 3). (C) When compared to 2′,5′-DHC (DHC, 10 μM), the non-hydroxylated chalcone (Cha, 10 μM) and 2′-HC (10 μM) had intermediate effects in increasing iGSH levels. Bars with different letters were statistically different from one another (n = 3, P < 0.05).
Fig. 4
Fig. 4
2′,5′-DHC induces an increase in GCL activity. (A) Cytosolic fractions of untreated (Con) and 2′,5′-DHC-treated AREc32 cells (15 μM, 16 h) were analyzed in their ability to catalyze the formation of γ-glutamyl-cysteine (γ-GC). 2′,5′-DHC induced a 20% increase in GCL activity. The reaction time was 30 min. Bars with different letters were statistically different from one another (n = 3, P < 0.05). (B) As shown by immunoblotting, 2′,5′-DHC (10 μM) induced the expression of HO-1 (34 kDa) (24 h treatment), an effect that was inhibited by MnTDE-1,3-IP5+ (MnP, 10 μM). 2′,5′-DHC had no significant effect on GCLC (73 kDa) levels. The experiment was repeated once. (C) As shown by immunoblotting, AREc32 cells treated (24 h) with 2′,5′-DHC (10 μM) alone or in combination with MnTDE-1,3-IP5+ (MnP, 10 μM) had no apparent effect on GCLC, GCLM nor GCL holoenzyme (holo-GCL) levels.
Fig. 5
Fig. 5
2′,5′-DHC-induced Nfr2/ARE response activity is ROS-independent. (A) The hydroxychalcones 2′-HC and 2′,5′-DHC (10 and 20 μM) induced the Nrf2/ARE response in AREc32 cells, as assessed by measuring luciferase activity (18 h treatment). (B) The Nrf2/ARE response was not inhibited by the antioxidants NAC (5 mM) nor MnTDE-1,3-IP5+ (MnP, 20 μM). Bars with different letters were statistically different from one another (n = 3, P < 0.05).
Fig. 6
Fig. 6
2′,5′-DHC-induced Nfr2/ARE response activity is inhibited by inhibitors of protein kinase pathways. (A-D) Luciferase activity was measured in 2′,5′-DHC-treated AREc32 cells co-treated with pharmacological inhibitors of various protein kinase pathways, namely SP600125 (JNK), SB203580 (p38MAPK), wortmannin (PI3K) and U0126 (ERK) (18 h treatment). (A) SP600125 (SP, 20 μM) and (B) SB203580 (SB, 20 μM) inhibited 15 μM 2′,5′-DHC-induced luciferase activity by 43% and 61%, respectively, while (C) wortmannin (Wort, 0.1 μM) had no significant effect. (D) The inhibitor of the ERK pathway U0126 (10 μM) induced the activation of the Nrf2/ARE pathway and this effect was additive to 2′,5′-DHC co-treatment. (E) SB203580 (SB, 20 μM) and SP600125 (SP, 20 μM) and wortmannin (Wort, 0.1 μM) were tested in their ability to inhibit 2′,5′-DHC-induced GSH synthesis (24 h treatment). Both SB203580 and SP600125 had an important inhibitory effect, while wortmannin had a slight effect. Bars with different letters were statistically different from one another (n = 3, P < 0.05).
Fig. 7
Fig. 7
2′,5′-DHC-induced phosphorylation of c-Jun is ROS-dependent. (A) 2′,5′-DHC (DHC, 15 μM) induced the phosphorylation of c-Jun (48 kDa) while c-Jun levels remained the same (39 kDa) in AREc32 cells treated for 2 h, an effect that was inhibited by MnTDE-1,3-IP5+ (MnP, 10 μM), as shown by immunoblotting. The experiment was repeated once. (B) 2′,5′-DHC (DHC, 30 μM) induced an increase in luciferase activity in transformed 16HBE cells, an effect that was inhibited by MnTDE-1,3-IP5+ (MnP, 20 μM) (24 h treatment). Bars with different letters were statistically different from one another (n = 3, P < 0.05).

Similar articles

Cited by

References

    1. Lawrence NJ, McGown AT. The chemistry and biology of antimitotic chalcones and related enone systems. Curr Pharm Des. 2005;11:1679–1693. - PubMed
    1. Dimmock JR, Elias DW, Beazely MA, Kandepu NM. Bioactivities of chalcones. Curr Med Chem. 1999;6:1125–1149. - PubMed
    1. Go ML, Wu X, Liu XL. Chalcones: an update on cytotoxic and chemoprotective properties. Curr Med Chem. 2005;12:481–499. - PubMed
    1. Cheng JH, Hung CF, Yang SC, Wang JP, Won SJ, Lin CN. Synthesis and cytotoxic, anti-inflammatory, and anti-oxidant activities of 2′,5′-dialkoxylchalcones as cancer chemopreventive agents. Bioorg Med Chem. 2008;16:7270–7276. - PubMed
    1. Nam NH, Kim Y, You YJ, Hong DH, Kim HM, Ahn BZ. Cytotoxic 2′,5′-dihydroxychalcones with unexpected antiangiogenic activity. Eur J Med Chem. 2003;38:179–187. - PubMed

Publication types

MeSH terms